UNSPSC 51422511: Triclonide

This classification denotes a topical corticosteroid with the molecular formula C24H28CL3FO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PSM3RT117Z. European Medicines Agency schedules triclonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11276MIG. The term TRICLONIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, no. 10 1974, list 14. ).

UNSPSC 51422511 Triclonide, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The source record shows Seminole County, Florida soliciting naloxone and safe drug deactivation systems — pharmaceutical products and harm-reduction equipment — which fall outside the scope of triclonide, a pharmaceutical ingredient. The mismatch suggests either a tagging error in the state or local procurement system or a definitional gap in how the jurisdiction applies UNSPSC codes to health and safety procurements. No other recent opportunities appear under this code in the source.

Seminole County issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB had a response deadline of July 26, 2023, and required bidders to submit unit costs, drug-free workplace certification, E-Verify compliance, and specified insurance coverage including workers' compensation and commercial general liability. The contract offered an initial two-year term with an option for one-year renewal and included a three-month probationary termination provision. Potential FEMA funding introduced additional compliance requirements under the Clean Air Act and Federal Water Pollution Control Act.